DK2296686T3 - Orodispersibel desmopressin til forøgelse af indledende periode af søvn uforstyrret af nykturi - Google Patents

Orodispersibel desmopressin til forøgelse af indledende periode af søvn uforstyrret af nykturi

Info

Publication number
DK2296686T3
DK2296686T3 DK09751584.5T DK09751584T DK2296686T3 DK 2296686 T3 DK2296686 T3 DK 2296686T3 DK 09751584 T DK09751584 T DK 09751584T DK 2296686 T3 DK2296686 T3 DK 2296686T3
Authority
DK
Denmark
Prior art keywords
nycturia
initial period
increasing initial
orodispersible
desmopressin
Prior art date
Application number
DK09751584.5T
Other languages
English (en)
Other versions
DK2296686T4 (da
Inventor
Bjarke Mirner Klein
Jens Peter Norgaard
Brad Shumel
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41100519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2296686(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of DK2296686T3 publication Critical patent/DK2296686T3/da
Application granted granted Critical
Publication of DK2296686T4 publication Critical patent/DK2296686T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
DK09751584.5T 2008-05-21 2009-05-21 Orodispersibel desmopressin til forlængelse af indledende søvnfase uforstyrret af nykturi DK2296686T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5512008P 2008-05-21 2008-05-21
PCT/US2009/044860 WO2009143356A1 (en) 2008-05-21 2009-05-21 Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia

Publications (2)

Publication Number Publication Date
DK2296686T3 true DK2296686T3 (da) 2014-05-12
DK2296686T4 DK2296686T4 (da) 2018-01-02

Family

ID=41100519

Family Applications (5)

Application Number Title Priority Date Filing Date
DK17171155T DK3225250T3 (da) 2008-05-21 2009-05-21 Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi
DK09751584.5T DK2296686T4 (da) 2008-05-21 2009-05-21 Orodispersibel desmopressin til forlængelse af indledende søvnfase uforstyrret af nykturi
DK16165875.2T DK3085381T3 (da) 2008-05-21 2009-05-21 Orodispersibel desmopressin til forøgelse den initielle periode af søvn uforstyret af nyturi
DK13181216.6T DK2712622T3 (da) 2008-05-21 2009-05-21 Orodispergibel desmopressin til forlængelse af indledende søvnperiode, uforstyrret af nykturi.
DK17171152.6T DK3225249T3 (da) 2008-05-21 2009-05-21 Orodispergerbar desmopressin til at øge indledende periode med søvn uforstyrret af nykturi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK17171155T DK3225250T3 (da) 2008-05-21 2009-05-21 Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK16165875.2T DK3085381T3 (da) 2008-05-21 2009-05-21 Orodispersibel desmopressin til forøgelse den initielle periode af søvn uforstyret af nyturi
DK13181216.6T DK2712622T3 (da) 2008-05-21 2009-05-21 Orodispergibel desmopressin til forlængelse af indledende søvnperiode, uforstyrret af nykturi.
DK17171152.6T DK3225249T3 (da) 2008-05-21 2009-05-21 Orodispergerbar desmopressin til at øge indledende periode med søvn uforstyrret af nykturi

Country Status (16)

Country Link
US (2) US9974826B2 (da)
EP (5) EP3225250B1 (da)
JP (5) JP5767103B2 (da)
CA (1) CA2724653A1 (da)
DK (5) DK3225250T3 (da)
ES (5) ES2677548T3 (da)
HR (4) HRP20161066T1 (da)
HU (5) HUE041370T2 (da)
LT (5) LT3225249T (da)
LU (1) LUC00015I2 (da)
NO (3) NO3085381T3 (da)
PL (5) PL2296686T5 (da)
PT (5) PT2712622T (da)
SI (4) SI3085381T1 (da)
TR (2) TR201819189T4 (da)
WO (1) WO2009143356A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100286045A1 (en) * 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
LT3225249T (lt) * 2008-05-21 2019-01-10 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas pirminio miego periodo, nepertraukiamo nikturija, pailginimui
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
WO2015063602A1 (en) * 2013-10-29 2015-05-07 Ferring B.V. Desmopressin and blood glucose
US20210393562A1 (en) * 2018-10-17 2021-12-23 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for nocturnal polyuria
EP4137206A1 (en) * 2020-04-14 2023-02-22 Nippon Chemiphar Co., Ltd. Agent for improving quality of sleep
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4316893A (en) 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4285858A (en) 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
DE3275121D1 (en) 1981-12-11 1987-02-19 Wyeth John & Brother Ltd Process for preparing solid shaped articles
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IE60941B1 (en) 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4878892A (en) 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
DK365389D0 (da) 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5091186A (en) 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
TW279133B (da) 1990-12-13 1996-06-21 Elan Med Tech
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
SE9101022D0 (sv) 1991-01-09 1991-04-08 Paal Svedman Medicinsk suganordning
US6746678B1 (en) 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
AU653026B2 (en) 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
KR100256715B1 (ko) 1991-08-26 2000-05-15 스티븐 에프. 웨인스톡 치료제의 설하 또는 구강 투여를 위한 조성물
JP2807346B2 (ja) 1991-12-24 1998-10-08 山之内製薬株式会社 口腔内崩壊製剤及びその製造法
US5298256A (en) 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
CA2090738C (en) 1993-02-24 1996-05-21 Hema-Quebec Use of paf
SE9300937L (sv) 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5434121A (en) * 1993-03-25 1995-07-18 Mitsui Toatsu Chemicals, Incorporated Variety of Drechslera monoceras, weed control compositions containing the same as an effective ingredient and weed control methods using the same
SE501677C2 (sv) 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
CZ282456B6 (cs) 1993-06-29 1997-07-16 Ferring B. V. Kompozice pro nasální podání desmopressinu
US5500413A (en) 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5985835A (en) 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
US5674850A (en) 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
DK0710243T3 (da) 1993-06-29 2000-10-16 Ferring Bv Syntese af cykliske peptider
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
EP0736041B1 (en) 1993-11-17 2006-02-08 Athena Neurosciences, Inc. Transparent liquid for encapsulated drug delivery
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
JP2551742B2 (ja) 1994-05-23 1996-11-06 三星電機株式会社 医薬品投与用皮膚傷形成装置
DE4424800A1 (de) * 1994-07-14 1996-01-18 Philips Patentverwaltung Schaltungsanordnung zum Liefern von Speisespannungen
SE518619C2 (sv) 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
GB9502879D0 (en) 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
IL113459A (en) 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
US5843016A (en) 1996-03-18 1998-12-01 Physion S.R.L. Electromotive drug administration for treatment of acute urinary outflow obstruction
TW411277B (en) 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
US6230051B1 (en) 1996-06-18 2001-05-08 Alza Corporation Device for enhancing transdermal agent delivery or sampling
US5763398A (en) 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
FR2758195B1 (fr) 1997-01-09 1999-02-26 Sgs Thomson Microelectronics Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele
US5821230A (en) 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US6194407B1 (en) 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
US6511974B1 (en) 1997-07-30 2003-01-28 Wyeth Tricyclic vasopressin agonists
US5932745A (en) 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US7153845B2 (en) 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20040018241A1 (en) 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US6090803A (en) 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
US6148232A (en) 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
GB9827292D0 (en) 1998-12-12 1999-02-03 Univ Strathclyde Freeze drying
US6406455B1 (en) 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US20060025387A1 (en) 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6235900B1 (en) 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6344451B1 (en) 1999-02-04 2002-02-05 American Home Products Pyrrolobenzodiazepine carboxyamide vasopressin agonists
US6620807B1 (en) 1999-02-04 2003-09-16 Wyeth Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
CN1186098C (zh) 1999-02-15 2005-01-26 住友制药株式会社 在口腔中迅速崩解的片剂
WO2000048669A1 (en) 1999-02-18 2000-08-24 Biovalve Technologies, Inc. Electroactive pore
AR014640A1 (es) 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7060708B2 (en) 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
EP1296730B2 (en) 2000-01-07 2014-07-30 Valeritas, Inc. Injection device
US20070032410A1 (en) 2000-01-11 2007-02-08 Atossa Healthcare, Inc. Compositions and methods for the treatment of psychiatric disorders
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
US6348486B1 (en) 2000-10-17 2002-02-19 American Home Products Corporation Methods for modulating bladder function
ATE428466T1 (de) 2000-10-26 2009-05-15 Alza Corp Transdermales arzneistoffverabreichungssytem mit beschichteten mikrovorsprüngen
US7931614B2 (en) 2000-11-30 2011-04-26 Valeritas, Inc. Injection systems
EP1412017B1 (en) 2000-11-30 2016-04-13 Valeritas, Inc. Fluid delivery and measurement systems and methods
US9302903B2 (en) 2000-12-14 2016-04-05 Georgia Tech Research Corporation Microneedle devices and production thereof
WO2002050584A2 (en) 2000-12-21 2002-06-27 Biovalve Technologies, Inc. Microneedle array systems
MXPA03008349A (es) 2001-03-16 2004-10-15 Johnson & Johnson Parche transdermico para administrar fentanilo.
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
DK1381608T3 (da) 2001-04-12 2008-02-04 Wyeth Corp Cyclohexylphenylvasopressinagonister
DE60218646T2 (de) 2001-04-12 2007-11-22 Wyeth N-biphenylcarbonyl- und n-phenylpyridylcarbonyl substituierte bi- und tricyclische azepine und diazepine als vasopressin-agonisten
US7615234B2 (en) 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
GB2391480B (en) 2002-08-05 2007-02-28 Caretek Medical Ltd Drug delivery system
EP1426355B1 (en) 2001-09-13 2008-10-15 Kissei Pharmaceutical Co., Ltd. Crystals of hydroxynorephedrine derivative
US6723077B2 (en) 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
US6893655B2 (en) 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
EP1445253B1 (en) 2001-11-16 2009-08-05 Astellas Pharma Inc. 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof
DE60307082D1 (de) 2002-05-07 2006-09-07 Ferring Bv In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
US20040115167A1 (en) 2002-09-30 2004-06-17 Michel Cormier Drug delivery device and method having coated microprojections incorporating vasoconstrictors
CA2501389C (en) 2002-10-09 2013-01-08 Toray Industries, Inc. Remedies or preventives for frequent urination or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
EP1428526A1 (en) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
DE10259934B3 (de) 2002-12-20 2004-10-14 H.C. Starck Gmbh Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile
AR042815A1 (es) 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
WO2004096775A1 (ja) 2003-04-28 2004-11-11 Astellas Pharma Inc. ４，４－ジフルオロ－１，２，３，４－テトラヒドロ－５ｈ－１－ベンゾアゼピン誘導体又はその塩
US20060193825A1 (en) 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ATE369802T1 (de) 2003-06-30 2007-09-15 Alza Corp Verfahren zum beschichten von mikrovorsprüngen zum durchstechen der haut
DK1500390T3 (da) 2003-07-25 2005-09-19 Ferring Bv Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
CN1826099B (zh) 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
US6930932B2 (en) 2003-08-27 2005-08-16 Hewlett-Packard Development Company, L.P. Data signal reception latch control using clock aligned relative to strobe signal
JP2007508914A (ja) 2003-10-24 2007-04-12 アルザ・コーポレーシヨン 経皮薬剤送達を促進するための装置及び方法
JP2007510445A (ja) 2003-10-24 2007-04-26 アルザ・コーポレーシヨン 経皮薬剤送達促進用の前処置法及びシステム
JP4682144B2 (ja) 2003-10-31 2011-05-11 アルザ・コーポレーシヨン 微小突起列のための自己−作動性アプリケーター
EP1689419A4 (en) † 2003-11-10 2009-01-14 Reprise Biopharmaceutics Llc PHARMACEUTICAL COMPOSITIONS WITH LOW DOSES OF DESMOPRESSIN
EP1530967B1 (en) 2003-11-13 2006-05-03 Ferring B.V. Blister pack and solid dosage form comprising desmopressin
SI1550439T1 (sl) 2003-12-29 2006-08-31 Ferring Bv Postopek za pripravo trdne dozirne oblike dezmopresina
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
MXPA06007832A (es) 2004-01-09 2007-01-26 Johnson & Johnson Metodo y sistema de suministro de agente transdermico asistido por frecuencia.
DK1797109T3 (da) 2004-09-09 2016-04-11 Yeda Res & Dev Blandinger af polypeptider, sammensætninger indeholdende disse og fremgangsmåder til fremstilling deraf, og anvendelser deraf
US7097776B2 (en) 2004-10-22 2006-08-29 Hewlett-Packard Development Company, L.P. Method of fabricating microneedles
US20060093658A1 (en) 2004-10-26 2006-05-04 Gayatri Sathyan Apparatus and method for transdermal delivery of desmopressin
CN100339081C (zh) 2004-11-10 2007-09-26 范敏华 一种氯雷他定口腔崩解片剂的制备方法
US7180274B2 (en) 2004-12-10 2007-02-20 Aimtron Technology Corp. Switching voltage regulator operating without a discontinuous mode
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
EP1874756A1 (en) 2005-04-22 2008-01-09 Wyeth Chromane and chromene derivatives and uses thereof
JP2008538577A (ja) 2005-04-22 2008-10-30 ワイス ジヒドロベンゾフラン誘導体およびその使用
BRPI0610046A2 (pt) 2005-04-22 2010-05-25 Wyeth Corp derivados de benzodioxano e benzodioxolano e usos destes
GT200600164A (es) 2005-04-22 2007-03-14 Derivados de dihidrobenzofuranos y usos de los mismos
MX2007013021A (es) 2005-04-22 2008-01-11 Wyeth Corp Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c.
CA2606064A1 (en) 2005-04-24 2006-11-02 Wyeth Methods for modulating bladder function
CA2612005C (en) 2005-06-17 2013-10-29 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
EP1904158B1 (en) 2005-06-24 2013-07-24 3M Innovative Properties Company Collapsible patch with microneedle array
WO2007083323A2 (en) 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
WO2007098945A2 (en) 2006-03-02 2007-09-07 Ferring International Center S.A. Stable solid dosage form comprising desmopressin
WO2007127976A2 (en) 2006-05-01 2007-11-08 Georgia Tech Research Corporation Particle based molding
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
LT3225249T (lt) * 2008-05-21 2019-01-10 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas pirminio miego periodo, nepertraukiamo nikturija, pailginimui

Also Published As

Publication number Publication date
ES2710454T3 (es) 2019-04-25
HUE039013T2 (hu) 2018-12-28
PL2712622T3 (pl) 2017-01-31
NO2019021I1 (no) 2019-04-30
CA2724653A1 (en) 2009-11-26
EP3085381A1 (en) 2016-10-26
JP6506821B2 (ja) 2019-04-24
EP2296686A1 (en) 2011-03-23
PL3225250T3 (pl) 2020-02-28
SI3225249T1 (sl) 2019-02-28
HUS1900024I1 (hu) 2019-05-28
LTPA2017001I1 (lt) 2017-02-10
PT2296686E (pt) 2014-05-23
JP2016196514A (ja) 2016-11-24
JP2019123739A (ja) 2019-07-25
HRP20161066T1 (hr) 2016-10-21
DK2712622T3 (da) 2016-09-12
NO3085381T3 (da) 2018-09-15
PT3085381T (pt) 2018-05-18
DK3225250T3 (da) 2019-11-04
PT3225249T (pt) 2019-01-17
LT3225249T (lt) 2019-01-10
JP5767103B2 (ja) 2015-08-19
HUE039013T4 (hu) 2019-08-28
EP3225250B1 (en) 2019-08-21
EP2296686B2 (en) 2017-11-01
ES2462465T3 (es) 2014-05-22
EP3225249A1 (en) 2017-10-04
HRP20191854T1 (hr) 2019-12-27
ES2677548T3 (es) 2018-08-03
LT3225250T (lt) 2019-11-11
EP2712622B1 (en) 2016-07-13
EP2712622A1 (en) 2014-04-02
EP3225249B1 (en) 2018-11-07
DK2296686T4 (da) 2018-01-02
EP3225250A1 (en) 2017-10-04
HUE046050T2 (hu) 2020-01-28
SI2712622T1 (sl) 2016-10-28
PT3225250T (pt) 2019-10-15
JP6836618B2 (ja) 2021-03-03
WO2009143356A1 (en) 2009-11-26
HRP20180774T1 (hr) 2018-08-10
LT3085381T (lt) 2018-06-11
HUE041370T2 (hu) 2019-05-28
JP6258424B2 (ja) 2018-01-10
EP3085381B1 (en) 2018-04-18
SI3085381T1 (en) 2018-06-29
JP2015120761A (ja) 2015-07-02
SI3225250T1 (sl) 2019-11-29
EP2296686B1 (en) 2014-02-12
HRP20190114T1 (hr) 2019-03-08
ES2756706T3 (es) 2020-04-27
JP2018035198A (ja) 2018-03-08
PL2296686T3 (pl) 2014-07-31
US20180250357A1 (en) 2018-09-06
US9974826B2 (en) 2018-05-22
ES2462465T5 (es) 2018-02-28
TR201807224T4 (tr) 2018-06-21
HUE030409T2 (en) 2017-05-29
NO2296686T3 (da) 2014-07-12
JP6001121B2 (ja) 2016-10-05
DK3225249T3 (da) 2019-02-25
LTC2712622I2 (lt) 2020-02-10
LT2712622T (lt) 2016-09-26
PL2296686T5 (pl) 2018-06-29
DK3085381T3 (da) 2018-05-28
ES2596435T3 (es) 2017-01-09
PL3225249T3 (pl) 2019-05-31
US20090291880A1 (en) 2009-11-26
LUC00015I1 (da) 2017-04-19
PL3085381T3 (pl) 2018-09-28
LUC00015I2 (da) 2017-06-19
PT2712622T (pt) 2016-10-13
JP2011520980A (ja) 2011-07-21
TR201819189T4 (tr) 2019-01-21

Similar Documents

Publication Publication Date Title
BRPI1016125A2 (pt) meio de ancoragem
DK2271219T3 (da) Anvendelse af dithiin-tetracarboximider til bekæmpelse af fytopatogene svampe
DK3192520T3 (da) Terapeutiske midler til reducering af niveauerne af parathyreoideahormon
DK2262793T3 (da) Krystallinske former af nilotinib-hci
DK2853265T3 (da) Fremgangsmåder til at øge stabiliseringen af hypoxi-inducerbar faktor-1-alpha
BR112012003787A2 (pt) variantes de glicoamilase
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK2379878T3 (da) Beklædning til vindmøllevinger
DK3214083T3 (da) Fremgangsmåde til fremstilling af quinolonforbindelser
DK2296686T3 (da) Orodispersibel desmopressin til forøgelse af indledende periode af søvn uforstyrret af nykturi
DK2453858T3 (da) Fremgangsmåde
UA21424S (uk) Елемент мундштука
DK2516359T3 (da) Fremgangsmåde til fremstilling af ethylbenzen
DK2173197T3 (da) Fremgangsmåde
DK2306032T3 (da) Fastgørelseselement
DK2294043T3 (da) Fremgangsmåde til fremstilling af glycerolalkyletere
UY3860Q (es) Reloj
DE112010004152A5 (de) Stabilisiervorrichtung
DK200800145A (da) Fremgangsmåde til fremstilling af etiketter
FI20080435A (fi) Pylväsrakenne
ES1067161Y (es) Reloj de pulsera
CN300927966S (zh) 手表
CN300915864S (zh) 手表
CN300927964S (zh) 手表
TH101847B (th) ตัวเรือนนาฬิกา